Ausgewählte Veröffentlichungen

Seit 2020

2020

M. Schlander:

HTA agencies need evidence-informed deliberative processes:
Comment on “Use of evidence-informed deliberative processes by health technology assessment agencies around the globe".

Int J Health Policy Manag x(x) (2020): 1-4. DOI: 10.34172/ijhpm.2020.22 [Online-Version vorab verfügbar].

J.M. Heard, C. Vrinten, M. Schlander, C.M. Bellettato, C. van Lingen, M. Scarpa; MetabERN collaboration group:

Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network.

Orphanet Journal of Rare Diseases, (2020) Jan 6; 15(1): 3.